Clinical Insights in Geriatrics: The Special Challenges of Treating Older Adults with Type 2 Diabetes
Release Date: December-20-13
Credit Expiration Date: December-20-14
Senior care clinicians including primary care physicians, family physicians, long-term care physicians, nurses, consultant pharmacists, and others interested in the care of older adults with type 2 diabetes.
Family Physicians: 0.75 Prescribed credit
Nurses: 0.75 Contact Hours
Pharmacists: 0.75 Contact Hour (0.075 CEU)
Many older adults with type 2 diabetes (T2DM) are not achieving their goals for glycemic control. As the population continues to age and diabetes prevalence increases, it is important for senior care and primary care clinicians on the multidisciplinary team to remain current regarding evidence-based best practices in the management of T2DM in older adults. Senior care and primary care clinicians can improve outcomes in patients with T2DM by more consistently implementing strategies to improve glycemic control and reduce the risk of hypoglycemia and other treatment-related adverse events.
The goal of this continuing education activity is to expand the ability of senior care and primary care clinicians to adopt effective strategies in helping patients achieve their individualized glycemic goals while avoiding hypoglycemia and other treatment-related adverse events, ultimately improving outcomes for patients with T2DM.
Serena Cardillo, MD
Associate Professor of Medicine
Division of Endocrinology, Diabetes, & Metabolism
Hospital of the University of Pennsylvania
Peggy Soule Odegard, PharmD, CDE
Professor and Chair, Department of Pharmacy
School of Pharmacy
Clinical Pharmacist and Diabetes Educator, UW Medicine
University of Washington
Debra Hagerty, DNP, RN, NHA, CDP.CDONA, FACDONA
Department of Nursing
Armstrong Atlantic State University
Mary Campagnolo, MD, MBA
Family Physician, FAAFP, DABFM, CAQ-Geriatrics
Virtua-Family Medicine of Mansfield
It is the policy of the AAFP, ASCP, and NADONA to ensure balance, independence, objectivity and scientific rigor in all of its educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation. The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speaker's interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.
Dr. Cardillo discloses research support from AstraZeneca and Bristol-Meyers Squibb.
Dr. Odegard has no relevant financial conflicts to disclose.
Ms. Hagerty has no relevant financial conflicts to disclose.
Dr. Campagnolo has no relevant financial conflicts to disclose.
Ms. Dechevalier has no relevant financial conflicts to disclose.
Dr. Gerber has no relevant financial conflicts to disclose.
Ms. Barrett has no relevant financial conflicts to disclose.
Ms. Dornberger has no relevant financial conflicts to disclose.
Leslie Sharp has no relevant financial conflicts to disclose.
This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This Enduring Material activity, Clinical Insights in Geriatrics: The Special Challenges of Treating Older Adults with Type 2 Diabetes, has been reviewed and is acceptable for up to 0.75 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins December 20, 2013. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This knowledge-based activity, ACPE Universal Activity #0203-9999-13-156-H01-P, has been assigned 0.75 Contact Hour (0.075 CEU).
National Association of Directors of Nursing Administration LTC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity provides 0.75 contact hour by NADONA/LTC.
Participants must view the activity in its entirety, successfully complete the post-test, and submit an evaluation to receive continuing pharmacy education credit. Credit will be awarded for a score of 60% or better, and a statement may be printed immediately after passing the post-test.
There is no fee to participate in this educational activity.
This activity is supported by independent educational grants from Novo Nordisk and Daiichi Sankyo.
© 2013, MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, ASCP, NJAFP, NADONA, Novo Nordisk or Daiichi Sankyo. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.